Ahrens Brenton Karl 4
4 · Iterum Therapeutics plc · Filed Jun 25, 2021
Insider Transaction Report
Form 4
Ahrens Brenton Karl
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-23+64,706→ 64,706 totalExercise: $2.01Exp: 2031-06-22→ Ordinary Shares (64,706 underlying)
Footnotes (1)
- [F1]Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended, the shares subject to this option shall vest in full on June 23, 2022.